Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton. [electronic resource]
- Neoplasia (New York, N.Y.) 04 2017
- 346-353 p. digital
Publication Type: Journal Article
1476-5586
10.1016/j.neo.2017.02.006 doi
B7-H1 Antigen--metabolism Cell Line, Tumor Epidermal Growth Factor--pharmacology ErbB Receptors--metabolism Glycosylation Humans Models, Molecular Programmed Cell Death 1 Receptor--metabolism Protein Processing, Post-Translational--drug effects Signal Transduction--drug effects Ubiquitination--drug effects